367 completed, 89 recruiting, 80 unknown, 50 terminated. 190 Not applicable, 134 Phase 2, 102 Phase 3, 63 Phase 4, 38 Phase 1.
Follow Suppuration: new trials by email Literature Review of Suppuration trials Research Report on Suppuration
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of Methylene Blue Photodynamic Therapy for Treatment of Deep Tissue Abscesses Methylene Blue, Lipid Emulsion, Insertion of optical fiber - Abscess | Phase 2 | Not yet recruiting | University of Rochester | 150 | 2027-07-15 | 2026-11-17 |
| A Study of SL-325 in Participants With Hidradenitis Suppurativa SL-325, Placebo - Hidradenitis Suppurativa (HS) | Phase 2 | Not yet recruiting | Shattuck Labs, Inc. | 150 | 2027-01-01 | 2026-11-13 |
| Dose Reduced Alteplase in Managing Intrapleural Sepsis Reduced Dose Alteplase, Standard Dose Alteplase - Complicated Parapneumonic Effusion, Empyema, Pleural | Phase 3 | Not yet recruiting | Vanderbilt University Medical Center | 248 | 2027-01-01 | 2026-11-17 |
| A Real-world Study of Patients With Hidradenitis Suppurativa and High Cardiovascular Risk or Established Coronary Plaque Treated With Secukinumab Hidradenitis Suppurativa | Not yet recruiting | Novartis Pharmaceuticals | 34 | 2026-12-31 | 2026-11-10 | |
| Evaluating Antibiotic Course Upon Adequate Treatment of Empyema shortened antibiotic course, Standard medical treatment - Pleural Empyema | Not applicable | Not yet recruiting | University of Arizona | 50 | 2026-11-16 | 2026-10-07 |
| A Study of Early Secukinumab Treatment in Moderate to Severe Hidradenitis Suppurativa Patients Hidradenitis Suppurativa | Not yet recruiting | Novartis Pharmaceuticals | 186 | 2026-11-13 | 2026-10-20 | |
| VATS or Intrapleural Enzymatic Therapy for Patients With Empyema. VATS group, IET - Empyema, Pleural, Pleural Infections | Phase 4 | Recruiting | Amsterdam UMC | 164 | 2026-11-07 | 2026-11-10 |
| Comparative Study Between Laparoscopic and Open Appendectomy of Complicated Appendicitis Laparoscopic Appendectomy, Open Appendectomy - Appendicitis, Perforated Appendicitis | Not applicable | Not yet recruiting | Assiut University | 100 | 2026-11-01 | 2026-10-16 |
| Naproxen Versus Placebo as Adjunct Treatment of Cellulitis enteric-coated naproxen, Cephalexin Tablets, Placebo - Cellulitis, Skin Disease, Infectious | Phase 3 | Not yet recruiting | Ottawa Hospital Research Institute | 884 | 2026-11-01 | 2026-10-20 |
| A Single Dose of Intravenous Penicillin as an Adjunct to Oral Penicillin in the Treatment of Acute Tonsillitis, Peritonsillar Phlegmon, and Peritonsillar Abscess Benzylpenicillin, Isotonic NaCl (Placebo) - Acute Tonsillitis, Peritonsillar Abscess | Phase 4 | Recruiting | Tejs Ehlers Klug | 154 | 2026-11-01 | 2026-11-04 |
| Early Pathophysiology of Hidradenitis Suppurativa and Prediction of the Risk of Progression: a Prospective Cohort Biological samples and questionnaires, Analysis of residual skin tissue - Hidradenitis Suppurativa (HS) | Not applicable | Not yet recruiting | Assistance Publique - Hôpitaux de Paris | 200 | 2026-11-01 | 2026-11-06 |
| A Study to Explore the Tissue Level Effects of Remibrutinib in Adults With Moderate to Severe HS LOU064, Placebo - Hidradenitis Suppurativa | Phase 1 | Recruiting | Novartis Pharmaceuticals | 30 | 2026-10-29 | 2026-11-10 |
| Efficacy and Safety of Olatorepatide Versus Placebo in Adults With Moderate to Severe Hidradenitis Suppurativa Living With Overweight or Obesity Olatorepatide, Placebo - Hidradenitis Suppurativa | Phase 2 | Recruiting | Regeneron Pharmaceuticals | 300 | 2026-10-29 | 2026-11-10 |
| Moxifloxacin Versus Clindamycin in the Management of Odontogenic Maxillofacial Infectious Processes Clindamycin, Moxifloxacin (400 mg) - Odontogenic Infection, Maxillofacial Infection | Not applicable | Not yet recruiting | Nishtar Medical University | 60 | 2026-10-01 | 2026-10-16 |
| Does Adding a Fascial Layer to the Cartilage in Tympanoplasty for Large Tympanic Membrane Perforation Affect the Overall Results? Conchal Cartilage and Perichondrium Tympanoplasty, Conchal Cartilage, Perichondrium, and Temporalis Fascia Tympanoplasty - Tympanic Membrane Perforation, Otitis Media | Not applicable | Not yet recruiting | Assiut University | 50 | 2026-10-01 | 2026-09-22 |
| Skin-in-Sight: a Longitudinal Cohort Infrastructure for Standardized Remote Monitoring and the Evaluation of Digital Care Innovations in Chronic Skin Diseases Psoriasis, Eczema/Atopic Dermatitis | Not yet recruiting | Medisch Spectrum Twente | 1000 | 2026-10-01 | 2026-09-04 | |
| Botulinum Toxin Blockade of Neuronal Signals to Immune Cells as a Novel Treatment for Hidradenitis Suppurativa Botulinum Toxin A (Allergan, Inc, Irvine CA), Placebo - Hidradenitis Suppurativa (HS) | Phase 2 | Not yet recruiting | University of Massachusetts, Worcester | 40 | 2026-10-01 | 2026-09-10 |
| Retention of Vernix Caseosa in Newborns for Primary Prevention of Atopic Dermatitis Retention of Vernix Caseosa After Birth, Removal of Vernix Caseosa After Birth - Atopic Dermatitis | Not applicable | Recruiting | Pontificia Universidad Catolica de Chile | 1383 | 2026-09-29 | 2026-09-30 |
| Safety and Efficacy of Soquelitinib in Adults With Hidradenitis Suppurativa Soquelitinib - Hidradenitis Suppurativa (HS) | Phase 1 | Recruiting | Corvus Pharmaceuticals, Inc. | 25 | 2026-09-17 | 2026-10-15 |
| Safety and Efficacy of Roflumilast Foam 0.3% in Adolescent and Adult Subjects With Hidradenitis Suppurativa Roflumilast 0.3% topical foam - Hidradenitis Suppurativa (HS) | Phase 2 | Recruiting | Harrison Dermatology | 10 | 2026-09-10 | 2026-10-13 |
Showing 20 of 683. Sign in to see all of them.
Hidradenitis Suppurativa (283) · Cellulitis (157) · Abscess (111) · Empyema (35) · Empyema, Pleural (34) · Abdominal Abscess (31) · Infections (28) · Skin Diseases (28) · Hidradenitis (27) · Dermatitis, Atopic (24) · Psoriasis (23) · Soft Tissue Infections (22) · Wound Infection (22) · Pneumonia (19) · Skin Diseases, Bacterial (18)
Infections (655) · Skin and Connective Tissue Diseases (455) · Skin Diseases, Infectious (440) · Bacterial Infections and Mycoses (353) · Pathological Conditions, Signs and Symptoms (343) · Pathologic Processes (335) · Bacterial Infections (334) · Skin Diseases (320) · Skin Diseases, Bacterial (302) · Inflammation (300) · Sweat Gland Diseases (276) · Hidradenitis (256) · Connective Tissue Diseases (173) · Abscess (108)
Vancomycin (19) · Adalimumab (17) · Clindamycin (17) · Linezolid (14) · secukinumab (14) · Drainage (13) · Trimethoprim, Sulfamethoxazole Drug Combination (13) · Cephalexin (10) · Daptomycin (10) · Moxifloxacin (10) · Saline Solution (10) · Sodium Chloride (9) · Tissue Plasminogen Activator (9) · Amoxicillin-Potassium Clavulanate Combination (7) · Aztreonam (7)
Novartis Pharmaceuticals (22) · AbbVie (15) · Incyte Corporation (12) · GlaxoSmithKline (11) · Assiut University (9) · Pfizer (9) · Henry Ford Health System (8) · Children's Mercy Hospital Kansas City (6) · Montefiore Medical Center (6) · National Institute of Allergy and Infectious Diseases (NIAID) (6) · UCB Biopharma SRL (6) · University of California, San Francisco (6) · University of Miami (6) · Wyeth is now a wholly owned subsidiary of Pfizer (6) · Assistance Publique - Hôpitaux de Paris (5)
United States (312) · Canada (95) · Germany (79) · France (73) · Spain (67) · Poland (53) · Italy (47) · Netherlands (46) · Australia (40) · China (39) · Greece (39) · United Kingdom (39) · Denmark (36) · Belgium (30) · Bulgaria (30)
Hadar Lev-Tov, MD (5) · G. Ralph Corey, MD (4) · Shawn D St. Peter, MD (4)
PMID 27518661, PMID 29380251, PMID 30597021, PMID 30716446, PMID 31604104, PMID 34741280, PMID 34905144, PMID 34922058, PMID 36746171, PMID 41248770, PMID 42482599, PMID 42525209, PMID 20346539, PMID 20695801, PMID 21115456, PMID 22236226, PMID 23247938, PMID 24897082, PMID 27370913, PMID 27585969, PMID 29358292, PMID 32460374, PMID 32965495, PMID 33599960, PMID 34252397, PMID 34976290, PMID 34978076, PMID 38795716, PMID 39101698, PMID 39141589, PMID 39425517, PMID 40153232, PMID 40172122, PMID 40372667, PMID 40652434, PMID 40839197, PMID 41107641, PMID 41689425, PMID 42247110, PMID 42493571, PMID 10028110, PMID 10371477, PMID 11425832, PMID 11555797, PMID 11576584, PMID 12048413, PMID 12140476, PMID 12145720, PMID 12487041, PMID 12625969
2025 (9), 2023 (7), 2018 (5), 2009 (3), 2019 (3), 2004 (1), 2008 (1), 2015 (1), 2017 (1), I50HX002263 (1), K08AR080844 (1), K12TR004908 (1), K23DA054363 (1), KL2RR031974 (1), R01NR013888 (1)